Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT04074018
Eligibility Criteria:
Inclusion Criteria:
* Age \> 17 yo;
* Ambulatory patient;
* Motivation to participate to a rehabilitative facial program for six months;
* Patient consent to shaving (men) and no makeup (women) in order not to hamper evaluations the morning of the 4 visits of the study ;
* Signed informed consent;
* Affiliation to asocial security scheme.
Exclusion Criteria:
* Peripheral facial paresis of evolving tumoral etiology;
* Medical history of botulinum toxin injections in facial muscles during the last 6 months preceding inclusion or injections planned during the study;
* Medical history of facial surgery in the last two years preceding inclusion or planned during the study;
* Medical history of facial reanimation surgery needing specific rehabilitation (V-VII or XII-VII anastomosis or muscle transfer);
* Medical history of medical aesthetic facial treatments (hyaluronic acid/ lipofilling/laser/bracing wires) in the preceding two years before inclusion or planned during the study;
* Recurrent PFP;
* Implication in other research interventional protocol dealing with aesthetical aspect of the face or with PFP;
* Intercurrent pathology impeding the realization of the rehabilitation program during the study;
* Cognitive, mental or psychiatric troubles impeding the realization of the rehabilitation program or the capacity to attend both evaluations and follow-up consultations;
* Tutorship or guardianship patient.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04074018
Study Brief:
Protocol Section:
NCT04074018